Abramson Cancer Center – Abramson Cancer Center

Life Altering

Using healthy cells to fight cancer. Now for non-Hodgkin lymphoma »

Dr. Carl June working in the lab on developing CAR-T cell therapy

Carl June, MD, has been named one of TIME's 100 most influential people for his pioneering work in the development of CAR-T cell therapy at Penn Medicine.

Dr. Carl June, Amy Gutmann, Madlyn Abramson and team at the CAR-T therapy FDA approval celebration/flash mob

BREAKING NEWS

The first ever CAR-T cell therapy developed by Penn Medicine is now approved to treat patients with non-Hodgkin lymphoma (NHL).

Grand View Health, Now in Penn Cancer Network

Grand View Health in Sellersville, Pennsylvania is offering access to the expert care at the Abramson Cancer Center.

Top Cancer Hospital in the Nation

We are ranked #1 in the Philadelphia region and 7th in the nation for cancer care by U.S. News & World Report. View awards >

Is CAR-T Right For Me?

CAR-T cell therapy was recently approved by the FDA to treat young adults with acute lymphocytic leukemia and adults with non-Hodgkin lymphoma. There are also clinical trials available for all different types of cancer.

Whether you are newly diagnosed with cancer or looking for a second opinion, request a call back and find out if CAR-T is right for you.

Request a Call-Back